DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
20.61
-0.64 (-3.01%)
At close: Apr 16, 2026, 4:00 PM EDT
20.61
0.00 (0.00%)
After-hours: Apr 16, 2026, 4:00 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Conducting of Research and Development of Epicutaneous Immunotherapy Products | 15.73M | 4.84M | 5.71M | | | | | |
Conducting of Research and Development of Epicutaneous Immunotherapy Products Growth | 224.69% | -15.14% | -49.38% | | | | | |
| 15.73M | 4.84M | 5.71M | | | | | |
| 224.69% | -15.14% | -49.38% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 1,000.00 | 1,000.00 | 15.73M | 4.84M | 5.71M | | | | | |
| 0% | -99.99% | 224.69% | -15.14% | -49.38% | | | | | |
| 1,000.00 | 1,000.00 | 15.73M | 4.84M | 5.71M | | | | | |
| 0% | -99.99% | 224.69% | -15.14% | -49.38% | | | | | |
Source: S&P Global Market Intelligence.
